189 related articles for article (PubMed ID: 10660386)
1. Dofetilide for atrial fibrillation.
Ferraro P; Khawari A; Boden WE
N Engl J Med; 2000 Jan; 342(4):289; author reply 290. PubMed ID: 10660386
[No Abstract] [Full Text] [Related]
2. Dofetilide for atrial fibrillation.
Rubin SA
N Engl J Med; 2000 Jan; 342(4):289-90. PubMed ID: 10660387
[No Abstract] [Full Text] [Related]
3. Atrial fibrillation in heart failure.
Stevenson WG; Stevenson LW
N Engl J Med; 1999 Sep; 341(12):910-1. PubMed ID: 10486424
[No Abstract] [Full Text] [Related]
4. Dofetilide for the treatment of atrial fibrillation in patients with congestive heart failure.
Torp-Pedersen C; Moller M; Kober L; Camm AJ
Eur Heart J; 2000 Aug; 21(15):1204-6. PubMed ID: 10924306
[No Abstract] [Full Text] [Related]
5. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
Torp-Pedersen C; Møller M; Bloch-Thomsen PE; Køber L; Sandøe E; Egstrup K; Agner E; Carlsen J; Videbaek J; Marchant B; Camm AJ
N Engl J Med; 1999 Sep; 341(12):857-65. PubMed ID: 10486417
[TBL] [Abstract][Full Text] [Related]
6. Role of carvedilol in atrial fibrillation: insights from clinical trials.
Gheorghiade M; Lukas MA
Am J Cardiol; 2004 May; 93(9A):53B-7B. PubMed ID: 15144939
[TBL] [Abstract][Full Text] [Related]
7. [Dofetilide in patients with chronic heart failure and left ventricular dysfunction].
Latini R
Ital Heart J Suppl; 2000 Mar; 1(3):427-8. PubMed ID: 10815277
[No Abstract] [Full Text] [Related]
8. Safety and effectiveness of dofetilide for conversion of atrial fibrillation and nesiritide for acute decompensation of heart failure: a report from the cardiovascular and renal advisory panel of the Food and Drug Administration.
Grines CL
Circulation; 2000 May; 101(21):E200-1. PubMed ID: 10831533
[No Abstract] [Full Text] [Related]
9. Dofetilide for atrial fibrillation.
Med Lett Drugs Ther; 2000 May; 42(1078):41-2. PubMed ID: 10847114
[No Abstract] [Full Text] [Related]
10. Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study.
Singh SN
Card Electrophysiol Rev; 2003 Sep; 7(3):225-8. PubMed ID: 14739718
[TBL] [Abstract][Full Text] [Related]
11. Dofetilide (Tikosyn).
Song JC; White CM
Conn Med; 2000 Oct; 64(10):601-4. PubMed ID: 11100632
[No Abstract] [Full Text] [Related]
12. Pericardioversion dofetilide does not suppress immediate and subacute recurrences of persistent atrial fibrillation.
Van Noord T; Van Gelder IC; Crijns HJ
Circulation; 2001 Sep; 104(11):E57. PubMed ID: 11551891
[No Abstract] [Full Text] [Related]
13. [Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter].
Vergara G
Ital Heart J Suppl; 2001 Mar; 2(3):322-3. PubMed ID: 11307794
[No Abstract] [Full Text] [Related]
14. Therapeutical considerations in associated atrial fibrillation and heart failure.
Mitu O; Mitu F; Constantin S; Cojocaru E; Leon MM
Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):624-30. PubMed ID: 25341275
[TBL] [Abstract][Full Text] [Related]
15. Beta-blockers versus digoxin to control ventricular rate during atrial fibrillation.
Veloso HH; de Paola AA
J Am Coll Cardiol; 2005 Jun; 45(11):1905-6; author reply 1906-7. PubMed ID: 15936626
[No Abstract] [Full Text] [Related]
16. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
[TBL] [Abstract][Full Text] [Related]
17. Dofetilide and atrial fibrillation.
Benson LM; Powless D
Am J Nurs; 2003 Feb; 103(2):64AA-64CC, 64EE-64GG. PubMed ID: 12582342
[No Abstract] [Full Text] [Related]
18. [Indications of digoxin for the treatment of atrial fibrillation].
Quirós-López R; Noureddine-López M; Villena-Ruiz MA; García-Alegría J
Rev Clin Esp; 2011 Oct; 211(9):492-3. PubMed ID: 21592471
[No Abstract] [Full Text] [Related]
19. Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation.
Torp-Pedersen C; Brendorp B; Køber L
Expert Opin Investig Drugs; 2000 Nov; 9(11):2695-704. PubMed ID: 11060831
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes with digoxin vs. beta-blocker for heart rate control in permanent atrial fibrillation with heart failure.
Bisson A; Ding WY; Bodin A; Lip GYH; Fauchier L
Eur J Heart Fail; 2021 Sep; 23(9):1563-1565. PubMed ID: 34231295
[No Abstract] [Full Text] [Related]
[Next] [New Search]
